Sébastien L Peltier, PhD
Valbiotis
2
0
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jean-Marie BARD, Dr-PhD
UFR des Sciences Pharmaceutiques et Biologiques, Nantes, France
Shared therapeutic areas:
Worked with same sponsors:
David GENDRE, Dr
Biofortis Mérieux NutriSciences
Shared therapeutic areas:
Worked with same sponsors:
David Crowley, MD
KGK Science Inc.
Shared therapeutic areas:
Samuel Klein, MD
Washington University School of Medicine
Shared therapeutic areas:
Jack A Yanovski, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Shared therapeutic areas:
Lisa Porter, MD
Amylin Pharmaceuticals, LLC.
Shared therapeutic areas:
ali ismail, lecturer
Cairo University
Shared therapeutic areas:
David s Ludwig, MD, PhD
Boston Children's Hospital
Shared therapeutic areas:
Adrian Vella, MD
Mayo Clinic
Shared therapeutic areas:
Shirley Wang, PhD, ScM
Brigham and Women's Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes
All 2 trials loaded